TRAW
Traws Pharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Traws Pharma, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Traws Pharma, Inc.
0.30
Largest filed tie
—
Expected move
No implied move.
No implied move.
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Orbimed AdvisorsOrbimed | $1.0M | 19.54% | +98.71% | |
| 2 | Ally Bridge Group (NY)Ally Bridge Group (NY) | $663,033 | 12.77% | new | |
| 3 | Adage Capital Partners GPAdage Capital Partners GP | $615,609 | 11.86% | 0.00% | |
| 4 | ADAR1 Capital ManagementADAR1 | $504,065 | 9.71% | +287.89% | |
| 5 | Lynx1 Capital ManagementLynx1 | $471,801 | 9.09% | +3610.51% | |
| 6 | Ikarian CapitalIkarian Capital | $403,217 | 7.77% | −29.49% | |
| 7 | Sphera Funds ManagementSphera Funds | $336,043 | 6.47% | new | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $278,231 | 5.36% | +497.99% | |
| 9 | Jane Street GroupJane Street | $182,158 | 3.51% | +916.93% | |
| 10 | Alyeska Investment GroupAlyeska Investment | $138,618 | 2.67% | new | |
| 11 | Boothbay Fund ManagementBoothbay Fund | $112,948 | 2.18% | −31.15% | |
| 12 | Geode Capital ManagementGeodeindex-like | $93,915 | 1.81% | +44.44% | |
| 13 | HRT FinancialHRT Financial | $77,000 | 1.48% | new | |
| 14 | Kynam Capital ManagementKynam | $71,175 | 1.37% | new | |
| 15 | Dauntless Investment GroupDauntless Investment | $67,948 | 1.31% | −80.68% | |
| 16 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $45,953 | 0.89% | +71.40% | |
| 17 | Northern TrustNorthern Trustindex-like | $31,585 | 0.61% | new | |
| 18 | State StreetState Streetindex-like | $21,759 | 0.42% | 0.00% | |
| 19 | XTX TopcoXTX Topco | $15,257 | 0.29% | new | |
| 20 | SG Americas SecuritiesSG Americas Securities | $12,000 | 0.23% | new | |
| 21 | Virtu FinancialVirtu Financial | $11,000 | 0.21% | new | |
| 22 | BlackRockBlackRockindex-like | $8,383 | 0.16% | −0.15% | |
| 23 | Tower Research Capital LLC (TRC)Tower Research Capital LLC (TRC) | $4,336 | 0.08% | +29.72% | |
| 24 | Huntington National BankHuntington National Bank | $3,943 | 0.08% | new | |
| 25 | UBS GroupUBS | $2,909 | 0.06% | −14.85% |
31 managers report $5.2M of Traws Pharma on form 13F for the quarter ended Jun 30 '26. 8 of them hold 80% of it; Orbimed is largest at 19.54%.